Seebri Neohaler Dosage
Generic name: GLYCOPYRROLATE 15.6ug
Dosage form: capsule for inhalation
Drug class: Anticholinergic bronchodilators
Medically reviewed by Drugs.com. Last updated on Apr 22, 2024.
For oral inhalation only. Do not swallow SEEBRI capsules, as the intended effects on the lungs will not be obtained. SEEBRI capsules should only be used with the NEOHALER device.
The recommended dose of SEEBRI NEOHALER is the inhalation of the contents of one SEEBRI capsule twice-daily using the SEEBRI NEOHALER device.
SEEBRI NEOHALER should be administered at the same time of the day, (1 capsule in the morning and 1 capsule in the evening), every day. More frequent administration or a greater number of inhalations (more than 1 capsule twice-daily) of SEEBRI NEOHALER is not recommended.
Store SEEBRI capsules in the blister, and only remove IMMEDIATELY BEFORE USE with the NEOHALER device.
No dosage adjustment is required for geriatric patients, patients with hepatic impairment, or patients with mild to moderate renal impairment.
Frequently asked questions
More about Seebri Neohaler (glycopyrrolate)
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: anticholinergic bronchodilators
- Breastfeeding
Patient resources
Other brands
Robinul, Lonhala Magnair, Cuvposa, Glycate, ... +2 more
Professional resources
Other brands
Robinul, Lonhala Magnair, Cuvposa, Dartisla ODT, Glyrx-PF
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.